QA Testing

download/print PDF version
reload without photo
PharmLabs San Diego Certificate of Analysis
Sample SF D8 KCA
Delta9 THC ND THCa ND Total THC (THC + THCa) ND Delta8 THC 81.43%
Logo_coa
Sample ID  SD221018-039 (53734) Matrix   Concentrate (Inhalable Cannabis Good)
Tested for  Cassini USA
Sampled   - Received   Oct 18, 2022 Reported   Oct 20, 2022
Analyses executed   CAN+

CAN+ - Cannabinoids

Analyzed Oct 19, 2022  |  Instrument HPLC-VWD  | Method SOP-001
The expanded Uncertainty of the Cannabinoid analysis is approximately ±7.806% at the 95% Confidence Level
Analyte   LOD
mg/g
LOQ
mg/g
Result
%
Result
mg/g
Sample photography
Cannabidivarin (CBDV)   0.039 0.16 ND ND Open-uri20221018-4-ka1y34?1666118471
Cannabidiolic Acid (CBDA)   0.001 0.16 ND ND
Cannabigerol Acid (CBGA)   0.001 0.16 ND ND
Cannabigerol (CBG)   0.001 0.16 ND ND
Cannabidiol (CBD)   0.001 0.16 ND ND
Tetrahydrocannabivarin (THCV)   0.001 0.16 ND ND
Cannabinol (CBN)   0.001 0.16 1.91 19.12
Tetrahydrocannabinol (Δ9-THC)   0.003 0.16 ND ND
Δ8-tetrahydrocannabinol (Δ8-THC)   0.004 0.16 81.43 814.30
Cannabicyclol (CBL)   0.002 0.16 ND ND
Cannabichromene (CBC)   0.002 0.16 ND ND
Tetrahydrocannabinolic Acid (THCA)   0.001 0.16 ND ND
Total THC ( THCa * 0.877 + Δ9THC )       ND ND
Total THC + Δ8THC ( THCa * 0.877 + Δ9THC + Δ8THC )       81.43 814.30
Total CBD ( CBDa * 0.877 + CBD )       ND ND
Total CBG ( CBGa * 0.877 + CBG )       ND ND
Total Cannabinoids Analyzed       83.34 833.42